Union Budget 2026 Pivots Healthcare Strategy Towards Chronic Disease Management
The Union Budget 2026–27 signals a decisive shift in India’s healthcare priorities, aligning public investment more closely with the country’s rapidly rising burden of chronic and non-communicable diseases (NCDs). From biologics manufacturing and diagnostics to drug affordability and workforce capacity, the Budget places long-term disease management at the centre of health policy.
Presenting the Budget in Parliament on Saturday, Finance Minister Nirmala Sitharaman announced a ₹10,000 crore commitment over five years for Biopharma Shakti, a new initiative aimed at strengthening India’s capabilities in biologic medicines, therapies that are increasingly critical for conditions such as diabetes, cancer, and autoimmune disorders.
Unlock the Future of Digital Health — Free for 60 Days!
Join DHN Plus and access exclusive news, intelligence reports, and deep-dive research trusted by healthtech leaders.
Already a subscriber? Log in
Subscribe Now @ ₹499.00Stay tuned for more such updates on Digital Health News
Follow us
